Valion Bio Inc (VBIO) Directors and Executive Officers

Officers & Directors

Jennifer Ernst, age 57, is the former Chief Executive Officer and Director. She co-founded the company and served as CEO and director from September 2016 to March 2026, and as Chief Financial Officer from September 2016 to July 2021. Prior to this, she was CEO of the U.S. subsidiary of Thin Film Electronics ASA from April 2011 to December 2015 and Chief Strategy Officer of Thin Film Electronics ASA from January 2014 to December 2015. She also held various roles at Xerox PARC for over 20 years, including Director of Business Development, and served as a director and Chair of FlexTech Alliance. She holds an MBA from Santa Clara University. Lisa Wolf, age 63, has been the Chief Financial Officer since July 3, 2025, after serving as interim CFO from October 2024 to July 2025. She has over 30 years of experience in public accounting and private industry. She joined Murdock Martell in June 2022 as Vice President and previously spent eight years at Resonant, Inc., where she was Vice President of Finance and Chief Accounting Officer. She holds a B.S. in Business Administration from California State University, Northridge, and is a Certified Public Accountant. Michael K. Handley, age 55, has been the Chief Executive Officer and Director since March 3, 2026. He was previously Chief Operating Officer and President of Tivic Biopharma from February 2025 until March 2026. Further details are available in the Directors section.